Enhancement of ABL kinase catalytic efficiency by a direct binding regulator is independent of other regulatory mechanisms.
ABL family tyrosine kinases are tightly regulated by autoinhibition and phosphorylation mechanisms. These kinases maintain an inactive conformation through intramolecular interactions involving SH3 and SH2 domains. RIN1, a downstream effector of RAS, binds to the ABL SH3 and SH2 domains and stimulates ABL tyrosine kinase activity. RIN1 binding to the ABL2 kinase resulted in a large decrease in Km and a small increase in Vmax toward an ABL consensus substrate peptide. The enzyme efficiency (k(cat)/Km) was increased more than 5-fold by RIN1. In addition, RIN1 strongly enhanced ABL-mediated phosphorylation of CRK, PSTPIP1, and DOK1, all established ABL substrates but with unique protein structures and distinct target sequences. Importantly RIN1-mediated stimulation of ABL kinase activity was independent of activation by SRC-mediated phosphorylation. RIN1 increased the kinase activity of both ABL1 and ABL2, and this occurred in the presence or absence of ABL regulatory domains outside the SH3-SH2-tyrosine kinase domain core. We further demonstrate that a catalytic site mutation associated with broad drug resistance, ABL1T315I, remains responsive to stimulation by RIN1. These findings are consistent with an allosteric kinase activation mechanism by which RIN1 binding promotes a more accessible ABL catalytic site through relief of autoinhibition. Direct disruption of RIN1 binding may therefore be a useful strategy to suppress the activity of normal and oncogenic ABL, including inhibitor-resistant mutants that confound current therapeutic strategies. Stimulation through derepression may be applicable to many other tyrosine kinases autoinhibited by coupled SH3 and SH2 domains.
Cao
Xiaoqing
X
Department of Biological Chemistry, Molecular Biology Institute, David Geffen School of Medicine, UCLA, Los Angeles, California 90095, USA.
Tanis
Keith Q
KQ
Koleske
Anthony J
AJ
Colicelli
John
J
D000818:Animals; D002384:Catalysis; D002460:Cell Line; D005786:Gene Expression Regulation; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000235:genetics / Q000378:metabolism; D007700:Kinetics; D009154:Mutation / Q000235:genetics; D010766:Phosphorylation; D011485:Protein Binding; D016315:Proto-Oncogene Proteins c-abl / Q000235:genetics / Q000378:metabolism*; D018411:Spodoptera; D013379:Substrate Specificity
D047908:Intracellular Signaling Peptides and Proteins; C092117:RIN1 protein, human; D016315:Proto-Oncogene Proteins c-abl
Mol Cell Biol. 2003 Jun;23(11):3884-96
12748290
EMBO J. 1989 Jan;8(1):137-47
2496972
Nat Neurosci. 2003 Jul;6(7):717-23
12796783
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19466-71
17164333
Cell Signal. 2000 Oct;12(9-10):637-43
11080615
J Neurosci. 2005 Jun 29;25(26):6105-18
15987940
Immunity. 1997 Jun;6(6):773-82
9208849
J Cell Biol. 2004 May 10;165(3):407-19
15138293
Science. 2000 Sep 15;289(5486):1938-42
10988075
J Neurosci. 2007 Oct 10;27(41):10982-92
17928439
Science. 2001 Aug 3;293(5531):876-80
11423618
Curr Biol. 2005 May 10;15(9):815-23
15886098
Blood. 2006 Jun 15;107(12):4888-97
16497976
Nature. 1995 Feb 9;373(6514):536-9
7845468
Cell. 2002 Jan 25;108(2):247-59
11832214
Trends Cell Biol. 2004 Jan;14(1):36-44
14729179
Genes Dev. 1994 Apr 1;8(7):783-95
7926767
Genes Dev. 1999 Sep 15;13(18):2400-11
10500097
J Biol Chem. 2006 Oct 27;281(43):32714-23
16943190
Mol Cell Biol. 2008 Mar;28(5):1573-83
18160707
Cancer Cell. 2002 Aug;2(2):117-25
12204532
J Cell Sci. 2003 Jul 1;116(Pt 13):2613-26
12775773
Oncogene. 2001 Dec 6;20(56):8075-84
11781820
J Biol Chem. 2000 Nov 10;275(45):35631-7
10964922
Chem Biol. 2002 Feb;9(2):253-64
11880040
Mol Cell. 2000 Dec;6(6):1413-23
11163214
Nat Genet. 2005 Dec;37(12):1315-6
16258541
Proc Natl Acad Sci U S A. 1997 May 13;94(10):4954-9
9144171
J Biol Chem. 2001 May 11;276(19):16185-92
11279004
Blood. 2008 Jul 1;112(1):111-9
18305217
Cancer Res. 2007 Dec 15;67(24):11510-6
18089779
Genes Dev. 1999 Jan 15;13(2):163-75
9925641
Curr Biol. 1999 Mar 11;9(5):281-4
10074458
Science. 2004 Mar 19;303(5665):1800-5
15031492
Cell. 2008 Sep 5;134(5):793-803
18775312
Mol Cell Biol. 2006 Aug;26(16):6082-93
16880519
Cell. 2003 Mar 21;112(6):859-71
12654251
J Cell Biol. 2004 May 24;165(4):493-503
15148308
Mol Cell. 2006 Mar 17;21(6):787-98
16543148
Biochim Biophys Acta. 2008 May;1783(5):737-47
18328268
Biochemistry. 2008 Jan 22;47(3):1094-104
18161990
Cell Res. 2005 Jan;15(1):43-8
15686626
PLoS Biol. 2006 May;4(5):e144
16640460
J Biol Chem. 1999 Jan 29;274(5):2893-8
9915826
Cell Res. 2005 Jan;15(1):33-5
15686624
Mol Biol Cell. 2007 Oct;18(10):3860-72
17652459